SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis
0 references·9 citing·35 second hop
Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis (1998)Screening for human T cell leukaemia/lymp…Reconsideration of blood donation testing strategy for human T‐cell lymphotropic virus in Australia (2017)Reconsideration of blood dona…Emerging Infectious Threats to the Blood Supply: Seroepidemiological Studies in Iran - a Review (2013)Emerging Infectious Threats t…The outcome of donor screening for Human T‐Cell Lymphotropic Virus infection in the Netherlands (2011)The outcome of donor screenin…Cost‐effectiveness of additional blood screening tests in the Netherlands (2011)Cost‐effectiveness of additio…False‐reactive microbiologic screening test results in Swedish blood donors—how big is the problem? A survey among blood centers and deferred donors (2006)False‐reactive microbiologic …Uses and sources of data on long-term survival after blood transfusion (2003)Uses and sources of data on l…Economics of Transfusion (2002)Economics of TransfusionBullying in school: are short pupils at risk? Questionnaire study in a cohort (2000)Bullying in school: are short…Microbiology confirmatory tests for blood donors (1999)Microbiology confirmatory tes…The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)The NICE Cost-Effectiveness Threshold (2008)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Blood donor selection in European Union directives: room for improvement. (2016)Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis (2018)Blood donation and donor recruitment in Iran from 1998 through 2007: ten years' experience (2009)Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study (1995)Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood (1997)Long‐term survival in transfusion recipients in Sweden, 1993 (2001)Who may give blood? (1987)Long‐term follow‐up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot (1995)Intersecting Pools and Their Potential Application in Testing Donated Blood for Viral Genomes (1997)Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State (2011)The effect of short‐term, temporary deferral on future blood donation (1998)The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public (2002)The blood‐donation experience: perceived physical, psychological and social impact of blood donation on the donor (2003)Understanding the meaning of permanent deferral for blood donors (2007)Response rate of Malaysian blood donors with reactive screening test to transfusion medicine unit calls. (2009)Donor notification and counseling – Experience and challenges (2013)A survey of the nature and extent of bullying in junior/middle and secondary schools (1993)Bullying at school: what we know and what we can do (1994)Bullying in schools: self reported anxiety, depression, and self esteem in secondary school children (1998)An evaluation of the relationship between adult height and health‐related quality of life in the general UK population (2007)Measuring health‐related quality of life in adolescence (2007)Money and age in schools: Bullying and power imbalances (2014)Blood safety strategies for human T‐cell lymphotropic virus in Europe (2008)Human T‐cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada (2018)Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness (1995)Safety of the Blood Supply in the United States: Opportunities and Controversies (1997)Gains in Life Expectancy from Medical Interventions — Standardizing Data on Outcomes (1998)The health and welfare of Australia's Aboriginal and Torres Strait Islander peoples 1999 (1999)Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT (2002)Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Risk‐based decision making in transfusion medicine (2018)Malaria blood safety policy in five non-endemic countries: a retrospective comparison through the lens of the ABO risk-based decision-making framework. (2019)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2000Bullying in school: are short pupils at risk? Questionnaire study in a cohort129 cited
  • 2011Cost‐effectiveness of additional blood screening tests in the Netherlands35 cited
  • 2006False‐reactive microbiologic screening test results in Swedish blood donors—how big is the problem? A survey among blood centers and deferred donors33 cited
  • 2017Reconsideration of blood donation testing strategy for human T‐cell lymphotropic virus in Australia25 cited
  • 2011The outcome of donor screening for Human T‐Cell Lymphotropic Virus infection in the Netherlands18 cited
  • 2013Emerging Infectious Threats to the Blood Supply: Seroepidemiological Studies in Iran - a Review16 cited
  • 1999Microbiology confirmatory tests for blood donors15 cited
  • 2003Uses and sources of data on long-term survival after blood transfusion11 cited
  • 2002Economics of Transfusion8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work